JP2023527556A5 - - Google Patents
Info
- Publication number
- JP2023527556A5 JP2023527556A5 JP2022573585A JP2022573585A JP2023527556A5 JP 2023527556 A5 JP2023527556 A5 JP 2023527556A5 JP 2022573585 A JP2022573585 A JP 2022573585A JP 2022573585 A JP2022573585 A JP 2022573585A JP 2023527556 A5 JP2023527556 A5 JP 2023527556A5
- Authority
- JP
- Japan
- Prior art keywords
- manipulated
- engineered
- protein
- protein according
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032502P | 2020-05-29 | 2020-05-29 | |
| US63/032,502 | 2020-05-29 | ||
| PCT/US2021/034713 WO2021243122A2 (en) | 2020-05-29 | 2021-05-28 | Engineered coronavirus spike (s) protein and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527556A JP2023527556A (ja) | 2023-06-29 |
| JP2023527556A5 true JP2023527556A5 (https=) | 2024-06-04 |
Family
ID=78722816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573585A Pending JP2023527556A (ja) | 2020-05-29 | 2021-05-28 | 操作されたコロナウイルススパイク（ｓ）タンパク質およびその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4157345A4 (https=) |
| JP (1) | JP2023527556A (https=) |
| KR (1) | KR20230018394A (https=) |
| CN (1) | CN116802193A (https=) |
| AU (1) | AU2021279079A1 (https=) |
| BR (1) | BR112022023591A2 (https=) |
| CA (1) | CA3180554A1 (https=) |
| IL (1) | IL298131A (https=) |
| MX (1) | MX2022015040A (https=) |
| WO (1) | WO2021243122A2 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012323782B2 (en) | 2011-10-12 | 2017-04-06 | Vaxxas Pty Limited | Delivery device |
| US12194089B2 (en) | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
| WO2021229270A1 (es) | 2020-05-13 | 2021-11-18 | Laboratorio Avi-Mex, S.A. De C.V. | Vacuna recombinante contra covid-19 en vector viral |
| WO2021249011A1 (en) | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Hiv vaccine compositions, methods, and uses thereof |
| WO2021249116A1 (en) | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Coronavirus vaccine compositions, methods, and uses thereof |
| WO2022041760A1 (en) | 2020-08-31 | 2022-03-03 | Sichuan Clover Biopharmaceuticals, Inc. | Methods and compositions for purification of trimeric fusion proteins |
| US11918643B2 (en) | 2020-12-22 | 2024-03-05 | CureVac SE | RNA vaccine against SARS-CoV-2 variants |
| WO2023067193A2 (en) | 2021-10-22 | 2023-04-27 | BioNTech SE | Compositions for administration of different doses of rna |
| US20250122546A1 (en) | 2021-10-28 | 2025-04-17 | BioNTech SE | Rna constructs and uses thereof |
| AU2022398292A1 (en) | 2021-11-29 | 2024-06-13 | BioNTech SE | Coronavirus vaccine |
| WO2023147091A1 (en) | 2022-01-28 | 2023-08-03 | BioNTech SE | Coronavirus vaccine |
| WO2023196634A2 (en) * | 2022-04-08 | 2023-10-12 | Flagship Pioneering Innovations Vii, Llc | Vaccines and related methods |
| WO2024002985A1 (en) | 2022-06-26 | 2024-01-04 | BioNTech SE | Coronavirus vaccine |
| WO2024086575A1 (en) | 2022-10-17 | 2024-04-25 | BioNTech SE | Combination vaccines against coronavirus infection, influenza infection, and/or rsv infection |
| EP4608442A1 (en) | 2022-10-28 | 2025-09-03 | GlaxoSmithKline Biologicals S.A. | Nucleic acid based vaccine |
| EP4670167A1 (en) | 2023-02-24 | 2025-12-31 | BioNTech SE | Systems and methods for modifying synthetic antigens to promote personalized immune responses |
| EP4669348A1 (en) | 2023-02-24 | 2025-12-31 | BioNTech SE | IMMUNOGENEOUS COMPOSITIONS |
| WO2024243641A1 (en) * | 2023-06-02 | 2024-12-05 | Vaxxas Pty Limited | Covid vaccine delivered by hd-map |
| WO2024249848A2 (en) * | 2023-06-02 | 2024-12-05 | The Scripps Research Institute | Coronavirus s2 immunogens |
| WO2025106754A1 (en) | 2023-11-15 | 2025-05-22 | BioNTech SE | Coronavirus vaccine |
| FR3155424A1 (fr) | 2023-11-15 | 2025-05-23 | BioNTech SE | Compositions immunogènes contre le sars-cov-2 |
| WO2025179238A2 (en) | 2024-02-23 | 2025-08-28 | BioNTech SE | Coronavirus vaccine |
| WO2026047603A1 (en) | 2024-08-28 | 2026-03-05 | BioNTech SE | Sars-cov-2 immunogenic compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2970398B1 (en) * | 2013-03-13 | 2024-05-08 | The United States of America, as Represented by The Secretary, Department of Health and Human Services | Prefusion rsv f proteins and their use |
| US10538557B2 (en) * | 2015-09-02 | 2020-01-21 | Janssen Vaccines & Prevention B.V. | Stabilized viral class I fusion proteins |
| US10960070B2 (en) * | 2016-10-25 | 2021-03-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion coronavirus spike proteins and their use |
| US11890339B2 (en) * | 2018-08-03 | 2024-02-06 | The United States of Americam as represented by the Secretary, Department of Health and Human Services | Nipah virus immunogens and their use |
| CN111088283B (zh) * | 2020-03-20 | 2020-06-23 | 苏州奥特铭医药科技有限公司 | mVSV病毒载体及其病毒载体疫苗、一种基于mVSV介导的新冠肺炎疫苗 |
-
2021
- 2021-05-28 WO PCT/US2021/034713 patent/WO2021243122A2/en not_active Ceased
- 2021-05-28 AU AU2021279079A patent/AU2021279079A1/en active Pending
- 2021-05-28 KR KR1020227042842A patent/KR20230018394A/ko active Pending
- 2021-05-28 CA CA3180554A patent/CA3180554A1/en active Pending
- 2021-05-28 IL IL298131A patent/IL298131A/en unknown
- 2021-05-28 BR BR112022023591A patent/BR112022023591A2/pt unknown
- 2021-05-28 EP EP21811955.0A patent/EP4157345A4/en active Pending
- 2021-05-28 MX MX2022015040A patent/MX2022015040A/es unknown
- 2021-05-28 JP JP2022573585A patent/JP2023527556A/ja active Pending
- 2021-05-28 CN CN202180049973.2A patent/CN116802193A/zh active Pending